MSD

Pembrolizumab

Biodrugs/ Drugs
Cancer
Metastatic Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus that have progressed after First Line Standard Therapy
3Phase III in Spain, 2Phase II, 1Phase I